US Patent Issued to Arizona Board of Regents on Behalf of Arizona State University, Marv Enterprises on Jan. 13 for "Method, device, and product for treating a body fluid of a patient with an inflammatory cytokine storm by binding an antibody to a cytokine antigen in the body fluid to form an antigen-antibody complex that is removed from the body fluid to reduce the amount of the cytokines in the body fluid" (Arizona, Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,475, issued on Jan. 13, was assigned to Arizona Board of Regents on Behalf of Arizona State University (Scottsdale, Ariz.) and Marv Enterprises LLC (Hermitage, Pa.).

"Method, device, and product for treating a body fluid of a patient with an inflammatory cytokine storm by binding an antibody to a cytokine antigen in the body fluid to form an antigen-antibody complex that is removed from the body fluid to reduce the amount of the cytokines in the body fluid" was invented by Qiang Chen (Chandler, Ariz.), Collin Bradley Jugler (Mesa, Ariz.), Haiyan Sun (Chandler, Ariz.), Adrian Esqueda (Tempe, Ariz.) and Mitchell S. Felder (Hermitage, Pa.).

According to the abstract* released by the...